Multiple Sclerosis - GK Flashcards

(107 cards)

1
Q

An immunologic disorder marked by chronic inflammation of the central nervous system (CNS)

What disease is this?

A

Multiple Sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In MS, mononuclear cells infiltrate the _______ space between arteries and veins and the pia mater, axons are _______ and destroyed, and immunoreactive changes in ______ cells result in the formation of ______ in multiple areas of the CNS.

A

perivascular

demyelinated

glial

plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the key to the diagnosis of MS?

A

dissemination of these plaques in time and space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 types of MS?

A
  1. relapsing-remitting RR
  2. primary-progressive PP
  3. secondary-progressive SP
  4. progressive-relapsing or primary progressive with activity PR/PP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MS tx falls into what 3 categories?

A
  1. exacerbations: corticosteroids
  2. Disease modifying therapies DMT
  3. symptomatic therapies for spasticity, bladder and sensory sx, fatigue.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 5 FDA approved 1st gen agents used to tx MS?

A
  1. Avonex
  2. Rebif
  3. Interferon-B1b
  4. Pegylated Interferon-B1b
  5. Glatiramer acetate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA: alters expression and response to surface antigens enhancing immune cell activities

Dosage: IM

A

Avonex (Interferon-B1a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA: alters expression and response to surface antigens enhancing immune cell activities

Dosage: SQ

A

Rebif (Interferon B-1a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA:

  • Augments suppressor cell function and reduce IFN-γ secretion by activated lymphocyte
  • Macrophage-activating effect
  • Down regulates the expression of IFN-γ–induced class II MHC gene products on antigen-presenting glial cells
  • IFN suppresses T-cell proliferation and may decrease blood–brain barrier permeability

Dosage: SQ

A

Interferon B-1b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA: alters expression and response to surface antigens enhancing immune cell activities

Dosage: SQ

A

Pegylated Interferon-B-1a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA: mimics antigenic properties of myeling binding protein (MBP) and inhibits binding of MBP peptides to T-cell receptor complexes.

Dosage: SQ

A

Glatiramer acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Indication and Dose: relapsing, orally

MOA: sequesters circulating lymphocytes into secondary lymphoid organs & reduces infiltration of T-lymphocytes & macrophages into the CNS.

A

Fongolimod

sequesters like a cowboy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA: inhibits dihydroorotate dehydrogenase = prevent proliferation of peripheral lymphocytes (T&B cells). Reduces activation of lymphocytes in CNS, reduces inflammation and demyelination.

Dose & Indication: relapsing, orally

Which drug?

A

Teriflunomide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dose & Indication: relapsing, orally

MOA: Unknown-invitro nicotinic acid receptor agonist, invitro activator of Nrf2 pathway involved in cellular response to oxidative stress

A

Dimethyl Fumarate

“When you are di-ing, you need Oxygen and you fume if you don’t get it”

AKA

cellular response to oxidative stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dose & Indication: RRMS, 1st dose: IV for 5 days 2nd dose: IV for 3 days. Administer 2nd dose 12 mo after 1st tx.

Which drug?

A

Alemtuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What kind of MS would you use Ocrelizumab for?

A

relapsing or progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ADE: depression, flu-like sx, leukopenia, injection site rxn

Monitor: electrolytes, CBC, [LFT’s at baseline, 1 mo, and every 3 mo for a year, and every 6 mo thereafer], thyroid function, LVEF.

What drug is this?

A

Avonex (Interferon-B1a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Indication: Relapsing form of MS

**low potency

**avoid use in untreated severe depression**

What drug is this?

A

Avonex (Interferon B-1a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ADE: depression, flu-like sx, leukopenia, injection site rxn

Monitor: electrolytes, CBC, [LFT’s at baseline, 1 mo, and every 3 mo for a year, and every 6 mo thereafer], thyroid function, LVEF.

A

Rebif (Interferon-B-1a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Indication: Relapsing form of MS

_**high potency_

_**avoid use in untreated severe depression**_

What drug is this?

A

Rebif (Interferon-B1a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ADE: depression, flu-like sx, leukopenia, injection site rxn

Monitor: more frequent injection site rxns reported

What drug is this?

A

Interferon B-1b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Indication: Relapsing form of MS

**high potency, pregnancy category C

What drug is this?

A

IFN Beta 1b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ADE: depression, flu-like sx, leukopenia, injection site rxn

Monitor: electrolytes, CBC, [LFT’s at baseline, 1 mo, and every 3 mo for a year, and every 6 mo thereafer], thyroid function, LVEF.

What drug is this?

A

Pegylated IFN Beta 1a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
**Indication:** Remitting-Relapsing **\*\*avoid use in untreated severe depression\*\*** **Can premedicate or concurrently use an antipyertic/analgesic for flu-like sx** **What drug is this?**
Pegylated IFN B 1a
26
**ADE:** hypersensitivity, chest tightness, urticaria **Monitor:** MRI, tissue necrosis What drug is this?
Glatiramer Acetate
27
**Indication:** CIS, RRMS **Pregnancy category B** **What drug is this?**
Glatiramer acetate
28
**ADE:** macular r_etinal edema_, lymphocytopenia, AV block, infection, headache **Monitoring:** CBC, ECG, Varicella zoster antibody, BP, opthalmic exam, LFTs What drug is this?
Fingolimod ## Footnote **Sequesters like a cowboy**
29
Which drug requires **1st dose observation**?
Fingolimod ## Footnote **sequesters like a cowboy**
30
**Contraindications** for which drug? **DO NOT USE IN** pts receiving _class I & III antiarrhythmic drugs_ & those with _recent cardiac dz, 2nd & 3rd degree AV block._
Fingolimod ## Footnote **sequesters like a cowboy**
31
**ADE for which drug?** _Steven-Johnson Syndrome_, l_iver failure_, neutropenia, respiratory infection, _TB activation_, alopecia, neuropathy
Teriflunomide
32
Which drug would you monitor the following? CBC, **LFTs**, BO, pregnancy, **TB test**
Teriflunomide
33
\_\_\_\_\_\_\_\_\_ is an active metabolite of leflunomide.
Teriflunomide
34
\_\_\_\_\_\_\_\_ is contraindicated in **severe hepatic impairment.**
Teriflunomide
35
What is the main adverse effect of _Teri**flu**nomide_?
**_Stevens-Johnson syndrome_** \*\*begins with _**flu**-like symptoms_, followed by a **painful red or purplish rash** that spreads and blisters. The top layer of the skin then dies and sheds.
36
Which medication carries a **pregnancy category X rating**?
**Teriflunomide**
37
Which medication as an **active metabolite** and what is the name of the active metabolite and the medication?
**Medication:** Leflunomide **Active Metabolite:** Teriflunomide
38
**ADE:** _flushing_, rash, pruiritis, GI discomfort, lymphocytopenia, inc LFTs, _albuminuria_. **Monitoring:** CBC, LFTs
**Dimethyl Fumarate**
39
How do you minimize the **flushing** associated with **dimethyl fumarate**?
Take the medication with **food**
40
**MOA:** monoclonal antibody that **causes depletion of CD52-expressing** T, B, natural killer cells and monocytes. Which drug?
Alemtuzumab
41
**ADE:** _nasopharyngitis,_ UTI, _URI_, herpes viral infection, autoimmune dz, thyroid dz, _purpura, goodpastures syndrome_ **Monitoring:** CBC, thyroid fxn, antibodies to VZV, TB prior to tx, urinalysis
Aletuzumab
42
Premedicate w/**high dose corticosteroid** **immediately prior to infusion for 1st 3 days** You would do this before starting which drug?
Aletuzumab
43
Administer **herpes viral prophylaxis 1st day of tx** & continue for **atleast 2 mos** after completion of tx or **until CD4+ count atleast 200 cells/microliters** You would do this for which drug?
Ateluzumab
44
Use **birth control during tx** & for **4 months** following each tx course. You would do this for which drug?
Alezutumab
45
Which drug is contraindicated with HIV infection?
Alezutumab
46
Premedicate with **methylprednisolone and diphenhydramine 30-60 min prior** to each infusion before using this drug. Which drug?
Ocrelizumab
47
**ADE:** infusion rnx Infections: - nasopharyngitis - UTI - URI - Herpes viral infection - skin infections - neutropenia Which drug?
Ocrelizumab
48
Which ADEs does **Alemtuzumab have that separates it from Ocrelizumab**?
**autoimmune disorders** **thyroid disorders** **purpura** **goodpastures syndrome**
49
What would you screen for in a patient who is taking **Ocrelizumab**?
HBV, CNS changes
50
What drug is contraindicated in pts with HBV?
Ocrelizumab
51
Which drug has a risk for **progressive multifocal leukoencephalopathy (PML)**?
Ocrelizumab
52
MOA: **recombinant human anti-CD20 monoclonal antibody** that binds to the CD20 epitope _(different binding region on CD20 than rituximab)_ Which drug is this?
Ocrelizumab
53
Which drug is designed to **optimize B cell depletion by modification of the Fc region**, which **enhances antibody-dependent cell-mediated cytotoxicity** & **reduces complement-dependent cytotixicity** compared with rituximab?
Ocrelizumab
54
MOA: Inhibits _RNA and DNA synthesis_ **\*\*used in oncology for leukemias\*\*** Which drug is this?
Mitoxantrone
55
**ADE:** _bone marrow suppression_, neutropenia, _cardiotoxicity_, _AML_, nausea, vomiting, diarrhea, alopecia Which drug?
Mitoxantrone
56
What should you monitor for Mitoxantrone?
CBC, ECG, LVEF, LEFTs
57
There is a lifetime maximum dose to this drug due to the associated cardiac toxicity Which drug?
mitoxantrone
58
What **types of MS is mitoxantrone** indicated for?
SPMS, PRMS, worsening RRMS
59
MOA for which drug? ## Footnote **activated lymphocytes are denied entry past the blood-brain barrier**
Natalizumab
60
MOA for which drug? attaches to **VLA-1** and blocks its interaction with its ligand on CNS endothelium vascular cell adhesion molecule **(VCAM-1)**
Natalizumab
61
**ADE:** _PML,_ depression, fatigue, respiratory infection, _arthralgia_, _hepatotoxicity_ Which drug?
Natalizumab
62
What should you monitor in a patient taking Natalizumab?
JCV antibody infection MRI LFT
63
Which drug has a risk of IRIS when discontinued due to PML?
Natalizumab
64
a **first episode of neurologic sx** that lasts atleast **24 hrs**
CIS (clinically isolated syndromes)
65
What is the **"safety; tried & true" approach for relapsing-remitting** MS?
injection therapy with: **IFN B-1a (Avenox or Rebif)** OR **IFN B-1b** OR **glatiramer**
66
What is the **"convenience" approach for relapsing-remitting** MS?
oral therapy with **dimethyl fumarate, teriflunomide or fingolimide**
67
What is the **"efficacy" approach to relapsing-remitting** MS?
**Infusion monotherapy** with **natalizumab or ocrelizumab**
68
Exacerbations are the hallmark of early \_\_\_\_\_\_
RRMS
69
Relapses are based on ____ or ________ symptomatic presentations
**mono** or **poly**
70
What are signs of a relapse?
* Localization to the **optic nerve,** **spinal cord** or **brainstem** * **functional limitations** affecting daily life * **sx that continue to worsen over 2 weeks**
71
Exacerbations are treated with \_\_\_\_\_\_\_
high dose glucocorticoids
72
What high dose glucocorticoid is used to treat exacerbations? What is the response time of this drug?
**methylprednisolone IV** **3 to 5 days**
73
MOA: unknown but thought to improve recovery by **decreasing edema in the area of demyelination**
corticosteroids (methylprednisolone)
74
**T/F:** Corticosteroids have been shown to definitively affect dz progression
FALSE; they have **_NOT_** been shown to definitively affect dz progression.
75
When would you initiate methylprednisolone?
**Within 2 weeks of sx onset**
76
What are short term use ADE's of corticosteroids?
**sleep disturbance** **metallic taste**
77
What are ADE's of corticosteroids that would occur in pts with DM or those who have a predilection to DM?
elevation of blood sugar: would require the use of insulin
78
ADEs of l**onger durations of IV methylprednisolone**
**acne** **fungal infections** **mood alteration** Rare: GI hemorrhage
79
Which drug is also used for RA?
teriflunomide
80
If the pt **declines oral therapy**, what therapy option might provide the pt with a **safer alternative**?
IFN-Beta 1a/1b Galtiramer
81
What are the **1st line therapies** for MS?
**self-injected** medications IFN-Beta1a/1b **(Avonex, Rebif)** **Glatiramir Acetate**
82
1st line therapies decrease annualized relapse rate by about \_\_\_\_\_\_%
30
83
first line therapies decrease the formation of new \_\_\_\_\_\_\_\_\_
**white matter lesion**
84
Are first line DMT immediately efficacious for sx?
NO
85
When is efficacy of first line DMTs noted?
1-2 years after starting therapy
86
All IFNs exert their actions in the ______ and at the ______ level
**periphery and blood-brain barrier**
87
What is the overall purpose of IFNs?
to **balance the expression of pro and anti-inflammatory agents in the brain**, and **reduce the # of inflammatory cells that cross the blood brain barrier**.
88
This drug is a mixture of 4 amino acids which is antigenically similar to myelin basic protein L: alanine glutamic acid lysine tyrosine
glatiramer acetate
89
**This drug induces Th2 lymphocytes (bystander suppression @ site of MS lesion)**
**glutiramer acetate**
90
This drug reduces **inflammation, demyelination and axonal damage**
glutiramer acetate
91
Recent studies suggest that this drug may be associated with a neuroprotective effect by inducing BDNF
gultiramer acetate
92
Which medication has an indication for CIS and RRMS?
glutiramer acetate
93
Which interferon is considered a low potency medication?
Avonex
94
Which drug is category B pregnancy?
Glutiramer acetate
95
Our pt reports a PMH of depression. Which meds would be considered a possible contraindication?
IFN-Beta 1a & 1b
96
What is appropriate monitoring parameters for the IFN meds?
electrolytes, CBC, LFT, thyroid fxn, LVEF, depression
97
Chest tightness can occur along with flusing with which med?
Glatiramer acetate
98
When would you use **fingolimod, natalizumab, alemtuzumab and mitoxantrone**? ## Footnote **MANF**
cases of inadequate response or intolerance to 1st line agents ## Footnote **MANF**
99
What are the limitations of **mitoxantrone**?
**life time limit dosage of 140** **preggo category D** **secondary leukemia**
100
When is fingolimod contraindicated?
pts receiving class I and III antiarrhythmuc drugs and those with recent cardiac disease, 2nd & 3rd degree AV block
101
What is PML and what is the dz process?
Progressive multifocal leukoencephalopathy A viral infection that targets cells that make myelin: material that insulates nerve cells (neurons)
102
When is John Cunninhgham virus activated?
When a person's immune system is compromised
103
When is mitoxantrone indicated?
SPMS PRMS worsening RRMS
104
Describe the drug interaction of fingolimod and ketoxonazole
ketoxconazole increases fingolimod serum concentration **(3A4 inhibition)**
105
What are possible starting treatments for RRMS?
IFN glatiramer acetate fingolimod teriflunomide dimethyl fumarate
106
Pt has experienced 3 exacerbations in the last 9 months and the sx are worsening with each exacerbation and his recovery is taking longer. What option is available if this pt is wanting a regimen that is convenient?
Teriflunomide or dimethyl fumarate (BG-12) Can be taken ORALLY
107